Narrow Results

AUSTRALIA — Childhood CT scans slightly raise cancer risk.

AUSTRALIA — There's a very simple solution to your lack of vitamin D.

INDIA — India develops cheap rotavirus vaccine.

JAPAN — 'Tug of war' method to measure the copy number limits of all genes in budding yeast.

SINGAPORE — SG Austria co-edits just released book on living cell bioencapsulation.

SINGAPORE — Nano Today's 2013 impact factor increases from 15.355 to 17.689.

SINGAPORE — Cholesterol beats coronaviruses, Avian flu and Swine flu.

THE PHILIPPINES — Philippines maps out plan to switch to 100% renewables in 10 years.

EUROPE — Roche launches first sugar-transferase for new glyco-engineering portfolio.

EUROPE — Older liver cancer patients respond to radioembolization equally as well as younger patients.

NORTH AMERICA — Protein helps colon cancer move and invade.

NORTH AMERICA — FDA approval of VIBATIV(R) (telavancin) for the treatment of bacterial pneumonia.

NORTH AMERICA — “On Demand Medical Research” is up and running.

UNITED KINGDOM — Diabetes rises sharply among UK's young adults.

UNITED KINGDOM — 'Mental illness' isn't all about brain chemistry: it's about life.

UNITED KINGDOM — Public to see impact of medical research funding.

SINGAPORE – VIVA Foundation and NUS Launches $10 Million Cancer Research Centre for Childhood Leukaemia.

SINGAPORE – Discovery Paves the Way for Potential Genetics-Guided Precision Medicine for Paediatric Leukaemia Patients.

SINGAPORE – Partnership between Sony and Alder Hey Children's Hospital Drives Innovation in Children's Healthcare.

UNITED STATES – UGA Researchers Make Link between Genetics and Aging.

UNITED STATES – Latin Dancing may Have Health Benefits for Older Adults.

UNITED STATES – Interferon Not Beneficial for Most Stage III Melanoma.

UNITED STATES – Dissecting the Animal Diet, Past and Present.

UNITED STATES – Water Conservation Important to Many; Only Some Take Action.

UNITED KINGDOM – Innova Biosciences Introduces New LATEX One-Step Conjugation Kits.

UNITED KINGDOM – New Understanding of the Mechanism of Neurodegeneration Leads to a Novel Approach to Treatment for Alzheimer's Disease.

TAIWAN – Breakthrough in Homogeneous Antibody Development and a New Generation of Glycoarray Technology.

TAIWAN – Increasing Protein Synthesis by Leucine Ameliorates Synaptopathy Caused by Dementia, ALS and Autism.

Robots, A Potential Staple in Eye Surgery.

Interviews at Commonwealth Science Conference 2017.

Precision Medicine for Cancer Patients: Interview with Dr Allen Lai.

Survival of patients with childhood hematological malignancies has increased markedly in the past decades. To examine the fine-scale details of how this progress has occurred, we carried out Kaplan–Meier cause-specific survival analysis using the Surveillance Epidemiology and End Results (SEER) dataset for patients with childhood hematological malignancies — Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Lymphoblastic Leukemia and Myeloid Leukemia — diagnosed in five eras: 1983–1987; 1988–1992; 1993–1997; 1998–2002 and 2003–2007. We generated Kaplan–Meier estimates of survival for each of the first 24 years after diagnosis. These figures agree with previously reported five- and ten-year values and attest to the remarkable increase in survival that has occurred over the past three decades of medical progress. The trend towards progressively increasing survival shows no sign of slowing, suggesting that we may expect further increases in survival in the years ahead. Most of the increase in survival for childhood hematological malignancies has occurred by reducing the risk of death in the first two years after diagnosis. This may be largely explained by the fact that this is the time period when patients are at highest risk of death.

Over 600 children under the age of 14 years are diagnosed with a childhood cancer each year in Australia and more than 80% survive their therapy each year and move into adulthood. For the majority of children the battle against cancer is won, but cure is often accompanied by a range of adverse health events, some of which may manifest many years after ceasing therapy. Changes in therapeutic approaches and increased survival command the need for ongoing research that focuses on the long term health outcomes of childhood cancer survivors. In this chapter we examine common health problems that can manifest in survivors of childhood cancer and discuss some of the challenges for long term care in this area.